HBA Rising Stars are professionals in various sectors of the healthcare industry and are nominated by HBA's Corporate Partner organizations. Rising Stars represent various career stages and disciplines and meet the following criteria:
- Is an employee of an HBA Corporate Partner company
- Contributes significantly to your organization, preferably in numerous areas
- Exemplifies true leadership and is a role model for others
- Assists those in subordinate or peer positions and is a team player
- Exhibits dedication to the healthcare industry
- Is an true example of “top talent” that your organization wants to formally recognize
Rising Stars are honored as leaders in the healthcare industry along with other award recipients at the annual WOTY event which attracts over 2,000 industry women and men and Rising Stars receive significant recognition including:
- Personal recognition from the podium
- Inclusion in all promotional materials for the event
- Acknowledgement in the special May issue of PharmaVoice magazine
- Being highlighted on the HBA website
- Jessica Brueggeman, RN, MPH, CHES, Director, Behavioral Services, MicroMass Communications Inc.
- Cherrie Che, Ph.D., Senior Manager , Ernst & Young LLP
- Elizabeth Colston, M.D., Ph.D., Medical Director, Connexion Healthcare
- Doris Connell, Pharm.D., Director, Field Medical Affairs, Daiichi Sankyo Inc.
- Denise D'Andrea, M.D., FACP, Senior Medical Director, Cephalon Inc.
- Patricia Ensor, R.Ph., Senior VP, Kantar Health
- Camilla Graham, M.D., M.Ph., Senior Director, Medical Affairs, Vertex Pharmaceuticals Inc.
- Sarah Holloway, Ph.D., Senior VP, Strategic Planning, Sudler & Hennessey
- Kelly Lewis, Pharm.D., Senior Director, Medical Science Liaisons, Actelion Pharmaceuticals US Inc.
- Sheryl Lowenhar, R.Ph., VP, Managed Markets and CME, Epocrates
- Nancy Martin, M.D., Medical Director, Astellas Pharma Global Development, Astellas Pharma US Inc.
- Dawn Palace, Ph.D., VP of Strategic Solutions, Big Communications
- Gisela Paulsen, M.Pharm., Senior Director, BioOncology Marketing, Communications and Operations, Genentech Inc., a member of the Roche Group
- Kala Subramanian, Ph.D., VP, Global Head of Oncology Program Management, Novartis Pharmaceuticals Corp.
No comments:
Post a Comment